We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00162630
Recruitment Status : Completed
First Posted : September 13, 2005
Last Update Posted : September 15, 2006
IMK Fonden
Information provided by:
Hvidovre University Hospital

Brief Summary:
To evaluate the analgesic potential of an neural blockade (Fascia iliaca compartment) with local anaesthetics in patients with hip fracture immediately after arrival in the emergency department.

Condition or disease Intervention/treatment Phase
Hip Fracture Procedure: Fascia Iliaca Compartment Blockade Phase 4

Detailed Description:
Hip fracture patients have severe pain in the acute phase. Traditional analgesic treatment have consisted of intramuscular morphine with its associated side effects. The trial evaluates the Fascia iliaca compartment compared to regular opioid pain therapy in hip fracture patinets immediately after arrival at the emergency department.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase
Study Start Date : May 2003
Estimated Study Completion Date : March 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. Pain relief within 3 hours

Secondary Outcome Measures :
  1. Nausea
  2. Pain on transfer
  3. Discomfort with block placement

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Primary hip fracture suspected
  • able to give informed consent
  • no substance abuse
  • no regular opioid therapy
  • no opioid treatment within the last 6 hours
  • morphine intolerance
  • allergies to local anaesthetics

Exclusion Criteria:

  • Fracture ruled out on x-ray

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00162630

Hvidovre University Hospital
Hvidovre, Denmark, 2650
Sponsors and Collaborators
Hvidovre University Hospital
IMK Fonden
Study Director: Nicolai B Foss, MD Hvidovre University Hospital

ClinicalTrials.gov Identifier: NCT00162630     History of Changes
Other Study ID Numbers: HHSG-rct-04
First Posted: September 13, 2005    Key Record Dates
Last Update Posted: September 15, 2006
Last Verified: September 2006

Keywords provided by Hvidovre University Hospital:
Hip fracture, pain, regional anaesthesia, analgesia

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries